George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 217.00
Bid: 214.00
Ask: 220.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.804%)
Open: 217.00
High: 217.00
Low: 217.00
Prev. Close: 217.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Animalcare announces leadership change

3 Aug 2018 07:00

RNS Number : 7459W
Animalcare Group PLC
03 August 2018
 

 

3 August 2018

 

Animalcare Group plc

 

("Animalcare", the "Company" or the "Group")

 

Animalcare announces leadership change

 

Animalcare Group plc (AIM:ANCR), the pan-European animal health business, today announces that Chris Cardon will step down from his position as Chief Executive Officer. The Board has appointed Jenny Winter to succeed Chris as Chief Executive Officer with effect from 1 October 2018. Chris will remain on the Board of the Company as part of the executive management team, transitioning to Chief Strategy Officer as of 1 October 2018. Chris will continue to lead the Company's international strategic vision and acquisition strategy and be part of Jenny's leadership team.

Jenny joins Animalcare with over twenty years' experience working in big pharma in various senior commercial roles for AstraZeneca and GlaxoSmithKline. Most recently, Jenny was Vice-President of Respiratory products - Global Supply Chain and Strategy at AstraZeneca, a position she held from 2015. Roles at the company also include Vice-President Cardiology - Global Product and Portfolio Strategy, Commercial Director - Eastern Europe, Marketing Company President Hungary, where she led a major change programme to drive future success and Global Vice President, Group Public Affairs.

Jenny has also been CEO of the charity Barretstown, transforming it into a successful leading children's charity. Her work at the charity resulted in her being asked by Barretstown board member Dermot Gleeson, Chairman of Allied Irish Bank, to join the Board of the bank as a Non-Executive Director, a role she held from 2004 to 2010. Jenny has a BSc in Physiology and Pharmacology from the University of Southampton.

Jan Boone, Chairman of Animalcare Group plc, said: "We are excited to welcome Jenny Winter, whose strong and varied international experience make her ideally placed to continue to realise the full benefits of the recent reverse merger and continue to implement our clear strategy for growth in the attractive animal health market.

"The Board would like to thank Chris for his significant achievements as Chief Executive, overseeing the transformational merger with Ecuphar and the transition of Animalcare to an international animal health business. His extensive experience will continue to be invaluable to the Company in his new role and will be vital in the Company's plans for growth."

Jenny Winter, Chief Executive Officer Elect of Animalcare Group plc, said: "I am delighted to be joining Animalcare at a very exciting time for the Company. My focus will be on accelerating the strong foundation for growth that has been already laid by the Board and management team, focusing on consolidation, product development and maximising the potential of the Group's unique and highly compelling animal health portfolio."

Chris Cardon, Chief Executive Officer/Strategy Officer of Animalcare Group plc, said: "I am proud to have led Animalcare through a very significant period of development for the business. I am pleased to hand over the reins of the Company to Jenny to allow me to focus on the strategic vision for the business and I am confident that she is the right candidate to lead Animalcare in its next stage of its growth and development. I look forward to working with her closely to ensure the continued success of the Group and to drive sustained growth of the business."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 For further information, please contact:

 

Animalcare Group plc

Tel: 01904 487 687

Chris Cardon, Chief Executive Officer

 

Chris Brewster, Chief Financial Officer

 

 

 

 

 

Panmure Gordon (Nominated Adviser & Broker)

Tel: 020 7886 2500

Corporate Finance

 

Freddy Crossley / Emma Earl

 

 

Corporate Broking

 

 

James Stearns

 

 

 

 

 

Consilium Strategic Communications

Tel: 020 3709 5700

 

 

Amber Fennell

 

animalcare@consilium-comms.com

 

Chris Welsh

 

 

Olivia Manser

 

 

     

 

Additional information

 

In accordance with paragraph (h) of Schedule 2 of the AIM Rules for Companies, the following information required to be disclosed in relation to Ms Winter is set out below.

 

Jennifer Ann Julia Winter (also known as Hynes and Winter-Hynes), aged 58, is not and has not been a director or partner of any companies within the previous five years. Also, Ms Winter currently holds no beneficial interest in the Company.

 

There is no further information required to be disclosed in respect of Ms Winter under Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

 

About Animalcare Group plc

Animalcare is a pan-European sales, marketing and product development company focused on the veterinary and animal health sectors. The Company has operations across Europe with direct sales in seven countries (UK, Belgium, Netherlands, Spain, Portugal, Italy and Germany), and exports to approximately 40 markets worldwide through global partnerships. The Company sells over 300 products including pharmaceuticals, vaccines and nutraceuticals. Animalcare has a diverse pipeline of products in development and a strong network of distribution and in-license partnerships. For more information, please visit: www.animalcaregroup.co.uk 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUCWRUPRUAW
Date   Source Headline
15th Mar 20138:15 amRNSChange of Registered Office
4th Mar 20131:10 pmRNSHolding(s) in Company
21st Feb 20131:00 pmRNSGrant of Share Options
21st Feb 20137:00 amRNSHalf Yearly Report
11th Jan 20137:00 amRNSDirectorate Change
11th Jan 20137:00 amRNSPost-Close Trading Update & Notice of Results
3rd Jan 20137:00 amRNSSale of Buprecare ampoules resumed
21st Dec 20125:55 pmRNSDirector/PDMR Shareholding
19th Dec 20128:39 amRNSShare Allotment and Total Voting Rights
21st Nov 20126:30 pmRNSGrant of Share Options
6th Nov 20124:47 pmRNSResult of AGM
6th Nov 20127:00 amRNSAGM Statement
29th Oct 20127:00 amRNSChange of Name of Adviser
12th Oct 20129:15 amRNSAnnual Report and Notice of Annual General Meeting
5th Oct 20121:44 pmRNSHolding(s) in Company
4th Oct 20127:00 amRNSGranting of a Marketing Authorisation
4th Oct 20127:00 amRNSFinal Results
6th Sep 20127:00 amRNSLaunch of New Veterinary Medicine
3rd Aug 20121:51 pmRNSGrant of Share Options
11th Jul 20127:00 amRNSPre-Close Trading Update
25th Jun 201210:05 amRNSReplacement re Grant of Share Options
25th Jun 20127:00 amRNSGrant of Share Options
24th May 20127:00 amRNSTrading update
1st May 20126:11 pmRNSShare Allotment and Total Voting Rights
30th Mar 20126:09 pmRNSTotal Voting Rights
28th Mar 20125:02 pmRNSHolding(s) in Company
23rd Mar 20127:00 amRNSMarketing Authorisation for Project Quattro
12th Mar 20127:00 amRNSDirectorate Change
1st Mar 20125:09 pmRNSReplacement re Share Allotment, Director S/hldg
27th Feb 20125:21 pmRNSShare Allotment, Director Shareholdings & TVR
20th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSChange of Adviser
26th Jan 20127:00 amRNSDirectorate Change
26th Jan 20127:00 amRNSPost-Close Trading Update & Notice of Results
4th Jan 201210:23 amRNSHolding(s) in Company
25th Nov 20115:12 pmRNSHolding(s) in Company
11th Nov 20117:00 amRNSDirectorate Change
4th Nov 20111:55 pmRNSGrants of Share Options to Directors
4th Nov 20111:51 pmRNSHolding(s) in Company
31st Oct 201112:00 pmRNSTotal Voting Rights
28th Oct 20117:00 amRNSAGM Statement
10th Oct 20115:04 pmRNSShare Allotment & Director Shareholdings
6th Oct 20117:00 amRNSAnnual Report and Notice of Annual General Meeting
4th Oct 20114:17 pmRNSHolding(s) in Company
4th Oct 20113:07 pmRNSShare Allotment & Director Shareholdings
30th Sep 201112:17 pmRNSTotal Voting Rights
19th Sep 20117:00 amRNSFinal Results
9th Sep 20113:09 pmRNSShare Allotment
2nd Sep 20112:45 pmRNSChange of Registered Office
1st Sep 20112:25 pmRNSShare Allotment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.